18.01.2011 - EU regulators said on Monday they were pressing pharmaceutical companies for more information on their patent deals with generic companies to make sure there is no delay in cheaper...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)